Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Fri Nov 28, 11:39AM CST

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

RPTX : 2.23 (+2.76%)
AXTA : 29.26 (-2.47%)
THS : 23.73 (-0.88%)
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR PR Newswire - Thu Nov 27, 10:13PM CST

NEW YORK , Nov. 27, 2025 /PRNewswire/ -- We wish you a Happy Thanksgiving and Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"),...

SEMR : 11.84 (unch)
RPTX : 2.23 (+2.76%)
AXTA : 29.26 (-2.47%)
WTG : 10.12 (unch)
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. Business Wire - Thu Nov 20, 4:25PM CST

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following the announcement on November 14, 2025 of the entering...

RPTX : 2.23 (+2.76%)
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights PR Newswire - Mon Nov 17, 11:00AM CST

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

SEE : 42.28 (-0.45%)
MRSN : 27.47 (-1.36%)
RPTX : 2.23 (+2.76%)
CDTX : 220.50 (-0.22%)
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders Business Wire - Fri Nov 14, 9:59PM CST

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

RPTX : 2.23 (+2.76%)
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire - Fri Nov 14, 6:56PM CST

MILWAUKEE , Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Repare (Nasdaq: RPTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

RPTX : 2.23 (+2.76%)
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. Business Wire - Fri Nov 14, 3:44PM CST

- Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 2026 - ...

RPTX : 2.23 (+2.76%)
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Business Wire - Mon Oct 13, 3:05PM CDT

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy...

RPTX : 2.23 (+2.76%)
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Business Wire - Fri Aug 8, 6:00AM CDT

Entered into worldwide licensing agreement with Debiopharm for lunresertib Evaluating strategic alternatives to maximize shareholder value ...

RPTX : 2.23 (+2.76%)
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options Newswire.ca - Mon Dec 23, 2024

/CNW/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies...

ONCY : 0.9807 (+8.19%)
RPTX : 2.23 (+2.76%)
IMRX : 6.69 (-0.74%)
ONC.TO : 1.42 (+2.16%)
RNXT : 0.9500 (+5.04%)
CRGX : 4.47 (-1.54%)

Barchart Exclusives

S&P Futures Gain With All Eyes on Key U.S. PCE Inflation Data Barchart - 10 minutes ago
December S&P 500 E-Mini futures (ESZ25) are trending up +0.16% this morning, extending their advance toward a new all-time high, while investors look ahead to the release of the Federal Reserve’s first-line inflation gauge. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot